TSX:PBH - Post Discussion
Post by
retiredcf on Jan 21, 2022 8:55am
TD
Have a $160.00 target. GLTA
Premium Brands Holding Corp.
(PBH-T) C$121.00
Q4/21 Preview and 2022 Outlook Event
-
Q4/21 results are expected to be reported on March 10. We forecast adjusted EBITDA of $106mm vs. $88mm last year. We are currently the Street-low. Consensus is at $113mm (range $106mm-$117mm). In 2022, we are forecasting a 10% increase in the quarterly dividend to $0.70 (from $0.64).
-
2022 outlook: We have lowered our 2022 EBITDA forecast by 5% as we attempt to, despite little visibility, fine-tune our assumptions around incremental supply- chain costs in H1/22. We are forecasting double-digit EBITDA growth to resume in H2/22 assuming that supply-chain pressure will start easing.
Impact: NEUTRAL
Main industry factors: 1) Elevated costs to persist in H1/22, given the ongoing supply-chain bottlenecks, high freight costs, and labour challenges; 2) Lingering pandemic risk poses a threat (i.e., increased absenteeism) to an already fragile supply chain; and 3) B.C. floods likely to affect Q4/21 results, but we expect a more muted impact on Q1/22 results.
Main company-specific factors: In 2022, we expect a tale of two halves starting with the ongoing pressure highlighted above, before giving way to the resumption of double-digit EBITDA growth, driven by: 1) PBH leveraging its sandwich capacity into more contract wins, given the rebound in consumer demand and the tight labour market faced by QSR/retail customers; 2) New program launches across its portfolio and expansions in the U.S.; 3) Production efficiencies from higher volume, facility expansions, and increased automation; and 4) Potential acquisitions (~15 files that would contribute ~$1.4bln to the top-line are in advanced/active stages); and 5) Selling price increases (i.e., ~+13%/+7% in SF/PFD) should start offsetting cost pressure, albeit more materially starting in H2/22.
Share-price catalysts: We believe that PBH's stock could benefit from major QSR/retailer contract wins, continued expansion of its growth initiatives, bigger synergy capture (i.e., value-added cross-selling) from the Clearwater acquisition, and potential M&A.
TD Investment Conclusion
In our view, there are very few CPG companies in North America with a better organic revenue growth outlook and/or M&A opportunities than PBH. Consequently, we still see sufficient upside to continue recommending to investors to buy PBH shares.
Be the first to comment on this post